Logo image of RYAM

RAYONIER ADVANCED MATERIALS (RYAM) Stock Fundamental Analysis

NYSE:RYAM - US75508B1044 - Common Stock

5.65 USD
+0.03 (+0.53%)
Last: 9/3/2025, 7:00:00 PM
5.65 USD
0 (0%)
After Hours: 9/3/2025, 7:00:00 PM
Fundamental Rating

2

RYAM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. RYAM has a bad profitability rating. Also its financial health evaluation is rather negative. RYAM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RYAM had negative earnings in the past year.
In the past year RYAM had a positive cash flow from operations.
In multiple years RYAM reported negative net income over the last 5 years.
RYAM had a positive operating cash flow in each of the past 5 years.
RYAM Yearly Net Income VS EBIT VS OCF VS FCFRYAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -25.28%, RYAM is doing worse than 86.75% of the companies in the same industry.
RYAM has a worse Return On Equity (-129.63%) than 87.95% of its industry peers.
RYAM has a Return On Invested Capital of 1.20%. This is in the lower half of the industry: RYAM underperforms 73.49% of its industry peers.
RYAM had an Average Return On Invested Capital over the past 3 years of 1.78%. This is below the industry average of 6.34%.
Industry RankSector Rank
ROA -25.28%
ROE -129.63%
ROIC 1.2%
ROA(3y)-2.37%
ROA(5y)-0.88%
ROE(3y)-6.96%
ROE(5y)-2.53%
ROIC(3y)1.78%
ROIC(5y)N/A
RYAM Yearly ROA, ROE, ROICRYAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

With a Operating Margin value of 1.38%, RYAM is not doing good in the industry: 77.11% of the companies in the same industry are doing better.
The Gross Margin of RYAM (8.44%) is worse than 83.13% of its industry peers.
RYAM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.38%
PM (TTM) N/A
GM 8.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.16%
GM growth 5Y22.12%
RYAM Yearly Profit, Operating, Gross MarginsRYAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RYAM is destroying value.
The number of shares outstanding for RYAM has been increased compared to 1 year ago.
Compared to 5 years ago, RYAM has more shares outstanding
The debt/assets ratio for RYAM has been reduced compared to a year ago.
RYAM Yearly Shares OutstandingRYAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RYAM Yearly Total Debt VS Total AssetsRYAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that RYAM is in the distress zone and has some risk of bankruptcy.
RYAM has a Altman-Z score of 1.13. This is in the lower half of the industry: RYAM underperforms 74.70% of its industry peers.
A Debt/Equity ratio of 2.10 is on the high side and indicates that RYAM has dependencies on debt financing.
The Debt to Equity ratio of RYAM (2.10) is worse than 81.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACC0.1
WACC11.92%
RYAM Yearly LT Debt VS Equity VS FCFRYAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.45 indicates that RYAM should not have too much problems paying its short term obligations.
The Current ratio of RYAM (1.45) is worse than 72.29% of its industry peers.
A Quick Ratio of 0.83 indicates that RYAM may have some problems paying its short term obligations.
RYAM has a Quick ratio of 0.83. This is amonst the worse of the industry: RYAM underperforms 80.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.83
RYAM Yearly Current Assets VS Current LiabilitesRYAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

RYAM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -194.29%.
RYAM shows a decrease in Revenue. In the last year, the revenue decreased by -4.90%.
The Revenue has been growing slightly by 2.64% on average over the past years.
EPS 1Y (TTM)-194.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2978.95%
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y5.02%
Revenue growth 5Y2.64%
Sales Q2Q%-18.27%

3.2 Future

The Earnings Per Share is expected to grow by 194.97% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.30% on average over the next years.
EPS Next Y-1124%
EPS Next 2Y209%
EPS Next 3Y194.97%
EPS Next 5YN/A
Revenue Next Year-10.38%
Revenue Next 2Y-3.16%
Revenue Next 3Y0.3%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RYAM Yearly Revenue VS EstimatesRYAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
RYAM Yearly EPS VS EstimatesRYAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

RYAM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 14.97, RYAM is valued correctly.
RYAM's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of RYAM to the average of the S&P500 Index (22.48), we can say RYAM is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.97
RYAM Price Earnings VS Forward Price EarningsRYAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

81.93% of the companies in the same industry are more expensive than RYAM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.84
RYAM Per share dataRYAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as RYAM's earnings are expected to grow with 194.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y209%
EPS Next 3Y194.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RYAM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAYONIER ADVANCED MATERIALS

NYSE:RYAM (9/3/2025, 7:00:00 PM)

After market: 5.65 0 (0%)

5.65

+0.03 (+0.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners77.04%
Inst Owner Change-6.81%
Ins Owners4.7%
Ins Owner Change16.11%
Market Cap378.55M
Analysts82.86
Price Target6.12 (8.32%)
Short Float %1.81%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1499.57%
Min EPS beat(2)-2198.35%
Max EPS beat(2)-800.79%
EPS beat(4)1
Avg EPS beat(4)-751.28%
Min EPS beat(4)-2198.35%
Max EPS beat(4)47.48%
EPS beat(8)3
Avg EPS beat(8)-633.7%
EPS beat(12)5
Avg EPS beat(12)-407.34%
EPS beat(16)6
Avg EPS beat(16)-410.33%
Revenue beat(2)0
Avg Revenue beat(2)-12.29%
Min Revenue beat(2)-13.53%
Max Revenue beat(2)-11.06%
Revenue beat(4)0
Avg Revenue beat(4)-7.38%
Min Revenue beat(4)-13.53%
Max Revenue beat(4)-0.8%
Revenue beat(8)2
Avg Revenue beat(8)-5.85%
Revenue beat(12)5
Avg Revenue beat(12)-2.77%
Revenue beat(16)6
Avg Revenue beat(16)-2.87%
PT rev (1m)-7.69%
PT rev (3m)-40%
EPS NQ rev (1m)-121.74%
EPS NQ rev (3m)-122.23%
EPS NY rev (1m)-13.21%
EPS NY rev (3m)-429.43%
Revenue NQ rev (1m)-6.75%
Revenue NQ rev (3m)-11.82%
Revenue NY rev (1m)-6.07%
Revenue NY rev (3m)-7.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.97
P/S 0.25
P/FCF N/A
P/OCF 3.32
P/B 1.11
P/tB 1.13
EV/EBITDA 6.84
EPS(TTM)-6.18
EYN/A
EPS(NY)0.38
Fwd EY6.68%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)1.7
OCFY30.17%
SpS22.68
BVpS5.11
TBVpS5.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.28%
ROE -129.63%
ROCE 1.52%
ROIC 1.2%
ROICexc 1.26%
ROICexgc 1.27%
OM 1.38%
PM (TTM) N/A
GM 8.44%
FCFM N/A
ROA(3y)-2.37%
ROA(5y)-0.88%
ROE(3y)-6.96%
ROE(5y)-2.53%
ROIC(3y)1.78%
ROIC(5y)N/A
ROICexc(3y)1.92%
ROICexc(5y)N/A
ROICexgc(3y)1.93%
ROICexgc(5y)N/A
ROCE(3y)2.25%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.16%
GM growth 5Y22.12%
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF N/A
Debt/EBITDA 4.68
Cap/Depr 94.04%
Cap/Sales 8.22%
Interest Coverage 0.25
Cash Conversion 74.26%
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.83
Altman-Z 1.13
F-Score5
WACC11.92%
ROIC/WACC0.1
Cap/Depr(3y)90.86%
Cap/Depr(5y)78.47%
Cap/Sales(3y)7.48%
Cap/Sales(5y)6.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2978.95%
EPS Next Y-1124%
EPS Next 2Y209%
EPS Next 3Y194.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.9%
Revenue growth 3Y5.02%
Revenue growth 5Y2.64%
Sales Q2Q%-18.27%
Revenue Next Year-10.38%
Revenue Next 2Y-3.16%
Revenue Next 3Y0.3%
Revenue Next 5YN/A
EBIT growth 1Y-53.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year445.73%
EBIT Next 3Y107.33%
EBIT Next 5YN/A
FCF growth 1Y-112.86%
FCF growth 3Y-11.5%
FCF growth 5YN/A
OCF growth 1Y-39.58%
OCF growth 3Y-4.42%
OCF growth 5Y37.19%